Basic Research
Copyright ©2008 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Sep 21, 2008; 14(35): 5403-5411
Published online Sep 21, 2008. doi: 10.3748/wjg.14.5403
Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line
Ying-Ying Lu, Da-Dao Jing, Ming Xu, Kai Wu, Xing-Peng Wang
Ying-Ying Lu, Da-Dao Jing, Kai Wu, Xing-Peng Wang, Department of Gastroenterology, Affiliated First People’s Hospital, Shanghai Jiao Tong University, Shanghai 200080, China
Ming Xu, Department of Gastroenterology, Wuxi Second People’s Hospital, Wuxi 214002, Jiangsu Province, China
Author contributions: Lu YY and Jing DD contributed equally to this work; Jing DD and Wang XP designed the research; Lu YY, Xu M and Wu K performed the research; Lu YY analyzed the data and wrote the paper.
Correspondence to: Dr. Da-Dao Jing, Department of Gastroenterology, Shanghai First People’s Hospital, Shanghai Jiao Tong University, 100 Haining RD, Hongkou District, Shanghai 200080, China.
Telephone: +86-21-63240090-3141 Fax: +86-21-66302029
Received: April 26, 2008
Revised: June 23, 2008
Accepted: June 30, 2008
Published online: September 21, 2008
Core Tip